Restasis Antitrust Suits Paused For MDL Panel Review
A Texas federal court on Friday stayed a series of lawsuits accusing Allergan PLC of violating antitrust laws to keep generics for the dry-eye medication Restasis off the market, until the...To view the full article, register now.
Already a subscriber? Click here to view full article